Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures

Arthritis and Rheumatism

Volumn 54, Issue 10, 2006, Pages 3152-3162

  Fearon, Ursula ^a   Mullan, Ronan ^a   Markham, Trevor ^a   Connolly, Mary ^a   Sullivan, Shane ^b   Poole, A Robin ^c   FitzGerald, Oliver ^a   Bresnihan, Barry ^a   Veale, Douglas J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; BROXURIDINE; COLLAGENASE 3; CYTOKINE; GLYCOSAMINOGLYCAN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MATRIGEL; MATRIX METALLOPROTEINASE; ONCOSTATIN M; PROTEOGLYCAN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CARTILAGE DEGENERATION; CELL ADHESION; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; EXTRACELLULAR MATRIX; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; RHEUMATOID ARTHRITIS; SUPERNATANT; SYNOVIUM;

ARTHRITIS, RHEUMATOID; CARTILAGE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 1; NEOVASCULARIZATION, PATHOLOGIC; ONCOSTATIN M; SYNOVIAL MEMBRANE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33750289939     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22161     Document Type: Article

References (50)

1. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33: 305-15.
2. Feldmann M, Brennan FM, Chantry D, Haworth C, Turner M, Abney E, et al. Cytokine production in the rheumatoid joint: implications for treatment [review]. Ann Rheum Dis 1990;49: 480-6.
3. Szekanecz Z, Koch AE. Endothelial cells in inflammation and angiogenesis [review]. Curr Drug Targets Inflamm Allergy 2005; 4:319-23.
4. Szekanecz Z, Kim J, Koch AE. Chemokines and chemokine receptors in rheumatoid arthritis [review]. Semin Immunol 2003: 1:15-21.
5. Sacre SM, Andreakos E, Taylor P, Feldmann M, Foxwell BM. Molecular therapeutic targets in rheumatoid' arthritis. Expert Rev Mol Med 2005;16:1-20.
6. Poole AR, Alini M, Hollander AP. Cellular biology of cartilage degradation. In: Henderson B, Edwards JC, Pettigher ER, editors. Mechanisms and models in rheumatoid arthritis. London: Academic Press; 1995. p. 163-204.
7. Mauviel A. Cytokine regulation of metalloproteinase gene expression [review]. J Cell Biochem 1993;53:288-95.
8. Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, et al. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 1992;255:1434-7.
9. Stahl N, Yancopoulos GD. The alphas, betas, and kinases of cytokine receptor complexes [review]. Cell 1993;74:587-90.
10. Okamoto H, Yamamura M, Morita Y, Harada S, Makino H, Ota Z. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Arthritis Rheum 1997;40:1096-105.
11. Hui W, Bell M, Carroll G. Detection of oncostatin M in synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis 1997;56:184-7.
12. Manicourt DH, Poilvache P, van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ. Synovial fluid levels of tumor necrosis factor α and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum 2000;43:281-8.
13. Richards CD, Brown TJ, Shoyab M, Baumann H, Gauldie J. Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat hepatocytes in vitro. J Immunol 1992;148:1731-6.
14. Cawston TE, Curry VA, Summers CA, Clark IM, Riley GP, Life PF, et al. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum 1998;41:1760-71.
15. Wijelath ES, Carlsen B, Cole T, Chen J, Kothari S, Hammond WP. Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology. J Cell Sci 1997;110:871-9.
16. Cawston TE, Ellis AJ, Humm G, Lean E, Ward D, Curry V. Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture. Biochem Biophys Res Comm 1995;215:377-85.
17. Langdon C, Leith J, Smith F, Richards CD. Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro. Arthritis Rheum 1997;40:2139-46.
18. Hui W, Rowan AD, Richards CD, Cawston TE. Oncostatin M in combination with tumor necrosis factor α induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum 2003;48:3404-18.
19. Li WQ, Dehnade F, Zafarullah M. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. J Immunol 2001;166:3491-8.
20. Nemoto O, Yamada H, Mukaida M, Shimmei M. Stimulation of TIMP-1 production by oncostatin M in human articular cartilage. Arthritis Rheum 1996;39:560-6.
21. Richards CD, Shoyab M, Brown TJ, Gauldie J. Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture. J Immunol 1993;150:5596-603.
22. Rowan AD, Koshy PJ, Shingleton WD, Degnan BA, Heath J, Vernallis AB, et al. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Arthritis Rheum 2001;44:1620-32.
23. Koshy PJ, Henderson N, Logan C, Life PF, Cawston TE, Rowan AD. Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann Rheum Dis 2002;61:704-13.
24. Bell MC, Carroll GJ, Chapman HM, Mills JN, Hui W. Oncostatin M induces leukocyte infiltration and cartilage proteoglycan degradation in vivo in goat joints. Arthritis Rheum 1999;42:2543-51.
25. Rowan AD, Hui W, Cawston TE, Richards CD. Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model. Am J Pathol 2003; 162:1975-84.
26. Langdon C, Kerr C, Hassen M, Hara T, Arsenault AL, Richards CD. Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am J Pathol 2000;157:1187-96.
27. Plater-Zyberk C, Buckton J, Thompson S, Spaull J, Zanders E, Papworth J, et al. Amelioration of arthritis in two murine models using antibodies to oncostatin M. Arthritis Rheum 2001;44: 2697-702.
28. Richards CD, Langdon C, Botelho F, Brown TJ, Agro A. Oncostatin M inhibits IL-1- induced expression of IL-8 and granulocyte-macrophage colony-stimulating factor by synovial and lung fibroblasts. J Immunol 1996;156:343-9.
29. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
30. Veale DJ. The role of arthroscopy in early arthritis [review]. Clin Exp Rheumatol 1999;17:37-8.
31. Fraser A, Fearon U, Reece R, Emery P, Veale DJ. Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheum 2001;44:2024-8.
32. McEvoy AN, Bresnihan B, FitzGerald O, Murphy EP. Cyclooxygenase 2-derived prostaglandin E2 production by corticotropin-releasing hormone contributes to the activated cAMP response element binding protein content in rheumatoid arthritis synovial tissue. Arthritis Rheum 2004;50:1132-45.
33. Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE. Evidence of IL-18 as a novel angiogenic marker. J Immunol 2001;167:1644-53.
34. Van Meurs J, van Lent P, Stoop R, Holthuysen A, Singer I, Bayne E, et al. Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity. Arthritis Rheum 1999;42:2074-84.
35. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986;883:173-7.
36. Faffe DS, Flynt L, Mellema M, Whitehead TR, Bourgeois K, Panettieri RA, et al. Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-β. Am J Physiol Lung Cell Mol Physiol 2005;288:1040-8.
37. Vasse M, Pourtau J, Trochon V, Muraine M, Vannier JP, Lu H, et al. Oncostatin M induces angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol 1999;19:1835-42.
38. Yao L, Pan J, Setiadi H, Patel KD, McEver RP. Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J Exp Med 1996;184: 81-92.
39. Cross A, Edwards SW, Bucknall RC, Moots RJ. Secretion of oncostatin M by neutrophils in rheumatoid arthritis. Arthritis Rheum 2004;50:1430-6.
40. Fiorelli V, Gendelman R, Samaniego F, Markham AD, Ensoli BJ. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 1995;95:723-34.
41. Nakatsuka K, Tanaka Y, Hubscher S, Abe M, Wake A, Saito K, et al. Rheumatoid synovial fibroblasts are stimulated by the cellular adhesion to T cells through lymphocyte function associated antigen-1/intercellular adhesion molecule-1. J Rheumatol 1997;24:458-64.
42. Cho DH, Song HK, Kang HS, Yoon SR, Lee HG, Pyun KH, et al. Ligation of ICAM-1 molecules inhibits target cell-induced granule exocytosis of IL-12-activated natural killer cells. Cell Immunol 2000;199:1-7.
43. Tanaka Y. The role of chemokines and adhesion molecules in the pathogenesis of rheumatoid arthritis. Drugs Today (Barc) 2001; 37:477-84.
44. Hanyuda M, Kasama T, Isozaki T, Matsunawa MM, Yajima N, Uchida H, et al. Activated leucocytes express and secrete macrophage inflammatory protein-1α upon interaction with synovial fibroblasts of rheumatoid arthritis via a β2-integrin/ICAM-1 mechanism. Rheumatology (Oxford) 2003;42:1390-7.
45. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry [review]. Cir Res 2003;92:5:827-39.
46. Ishiguro N, Ito T, Oguchi T, Kojima T, Iwata H, Ionescu M, et al. Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis. Arthritis Rheum 2001;44:2503-11.
47. Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, et al. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. . Arthritis Rheum 2003;48:3085-95.
48. Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, et al. Role of interleukin-1 and tumor necrosis factor a in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 2005;52:128-35.
49. Hui W, Barksby HE, Young DA, Cawston TE, McKie N, Rowan AD. Oncostatin M in combination with tumor necrosis factor α induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2. Ann Rheum Dis 2005;64:1624-32.
50. Pelletier JP, Martel-Pelletier J. Oncostatin M: foe or friend? [editorial]. Arthritis Rheum 2003;48:3301-3.